Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person CLTC(2-1634)insDGVSSVTQAGVQWRDLGSLQPSRARLPGHVAADHPPA-p-7Y-ALK(1058-1620) fusion [cytosol]

Class:IdEntityWithAccessionedSequence:9710835
_displayNameCLTC(2-1634)insDGVSSVTQAGVQWRDLGSLQPSRARLPGHVAADHPPA-p-7Y-ALK(1058-1620) fusion [cytosol]
_timestamp2023-04-02 09:36:10
compartment[Compartment:70101] cytosol
created[InstanceEdit:9710843] Rothfels, Karen, 2021-01-05
disease[Disease:9632617] diffuse large B-cell lymphoma
endCoordinate1634
hasModifiedResidue[FragmentInsertionModification:9710845] Insertion of residues 1058 to 1620 at 1635 from UniProt:Q9UM73 ALK
[FragmentReplacedModification:9710838] Replacement of residues 1634 to 1634 by YDGVSSVTQAGVQWRDLGSLQPSRARLPGHVAADHPPA
[ModifiedResidue:9699868] O4'-phospho-L-tyrosine at 1278
[ModifiedResidue:9699844] O4'-phospho-L-tyrosine at 1282
[ModifiedResidue:9699911] O4'-phospho-L-tyrosine at 1283
[ModifiedResidue:9699796] O4'-phospho-L-tyrosine at 1096
[ModifiedResidue:9699876] O4'-phospho-L-tyrosine at 1359
[ModifiedResidue:9699886] O4'-phospho-L-tyrosine at 1507
[ModifiedResidue:9699803] O4'-phospho-L-tyrosine at 1604
literatureReference[LiteratureReference:9710725] ALK activation by the CLTC-ALK fusion is a recurrent event in large B-cell lymphoma
modified[InstanceEdit:9832322] Orlic-Milacic, Marija, 2023-03-30
[InstanceEdit:9832524] Orlic-Milacic, Marija, 2023-04-02
nameCLTC(2-1634)insDGVSSVTQAGVQWRDLGSLQPSRARLPGHVAADHPPA-p-7Y-ALK(1058-1620) fusion
fullName evidence="36 37"Clathrin heavy chain 1
CLH1_HUMAN
referenceEntity[ReferenceGeneProduct:405001] UniProt:Q00610 CLTC [Homo sapiens]
species[Species:48887] Homo sapiens
stableIdentifier[StableIdentifier:9710860] R-HSA-9710835.2
startCoordinate2
(hasComponent)[Complex:9710879] CLTC(2-1634)-p-7Y ALK(1058-1620) fusion dimer [cytosol] [Homo sapiens]
(updatedInstance)[_UpdateTracker:9905695] Update Tracker - [EntityWithAccessionedSequence:9710835] CLTC(2-1634)insDGVSSVTQAGVQWRDLGSLQPSRARLPGHVAADHPPA-p-7Y-ALK(1058-1620) fusion [cytosol] - v85:[modifyName]
[Change default viewing format]
No pathways have been reviewed or authored by CLTC(2-1634)insDGVSSVTQAGVQWRDLGSLQPSRARLPGHVAADHPPA-p-7Y-ALK(1058-1620) fusion [cytosol] (9710835)